JPRN-UMIN000027005招募中未知
Treat and extend regimens with intravitreal aflibercept for macular edema secondary to branch retinal vein occlusion - Treat and extend intravitreal aflibercept for branch retinal vein occlusion
Jikei daisan hospital0 个研究点目标入组 50 人开始时间: 2019年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they had received treatment such as glaucoma or vitreous surgery and cataract surgery within 3 months; and if they had diabetic retinopathy or central retinal vascular occlusion.
研究者
相似试验
已完成
不适用
Combination therapy of intravitreal aflibercept and topical bromfenac for RVOretinal vein occlusionJPRN-UMIN000022988Juntendo Urayasu Hospital40
Unknown
4 期
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910Exudative Age-related Macular DegenerationNCT01961414Palmetto Retina Center, LLC45
尚未招募
3 期
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
尚未招募
不适用
Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Corticosteroid for Macular EdemaKCT0007766Hallym University Medical Center-Kangnam188
Unknown
1 期
Intense Treatment Regimen With Intravitreal Aflibercept InjectionNeovascular Age-Related Macular DegenerationNCT03594461Vitreous -Retina- Macula Consultants of New York30